Rittirsch Daniel, Battegay Edouard, Zimmerli Lukas U, Baulig Werner, Spahn Donat R, Ossendorf Christian, Wanner Guido A, Simmen Hans-Peter, Werner Clément Ml
Division of Trauma Surgery, University Hospital Zurich, Switzerland.
Patient Saf Surg. 2012 Jan 5;6(1):1. doi: 10.1186/1754-9493-6-1.
Malignant pheochromocytoma is a neuroendocrine tumor that originates from chromaffin tissue. Although osseous metastases are common, metastatic dissemination to the spine rarely occurs.Five years after primary diagnosis of extra-adrenal, abdominal pheochromocytoma and laparoscopic extirpation, a 53-year old patient presented with recurrence of pheochromocytoma involving the spine, the pelvis, both proximal femora and the right humerus. Magnetic resonance imaging and computed tomography revealed osteolytic lesions of numerous vertebrae (T1, T5, T10, and T12). In the case of T10, total destruction of the vertebral body with involvement of the rear edge resulted in the risk of vertebral collapse and subsequent spinal stenosis. Thus, dorsal instrumentation (T8-T12) and cement augmentation of T12 was performed after perioperative alpha- and beta-adrenergic blockade with phenoxybenzamine and bisoprolol.After thorough preoperative evaluation to assess the risk for surgery and anesthesia, and appropriate perioperative management including pharmacological antihypertensive treatment, dorsal instrumentation of T8-T12 and cement augmentation of T12 prior to placing the corresponding pedicle screws did not result in hypertensive crisis or hemodynamic instability due to the release of catecholamines from metastatic lesions.To the authors' knowledge, this is the first report describing cement-augmentation in combination with dorsal instrumentation to prevent osteolytic vertebral collapse in a patient with metastatic pheochromocytoma. With appropriate preoperative measures, cement-augmented dorsal instrumentation represents a safe approach to stabilize vertebral bodies with metastatic malignant pheochromocytoma. Nevertheless, direct manipulation of metastatic lesions should be avoided as far as possible in order to minimize the risk of hemodynamic complications.
恶性嗜铬细胞瘤是一种起源于嗜铬组织的神经内分泌肿瘤。虽然骨转移很常见,但转移至脊柱的情况很少发生。在肾上腺外腹部嗜铬细胞瘤初次诊断并接受腹腔镜切除术后五年,一名53岁患者出现嗜铬细胞瘤复发,累及脊柱、骨盆、双侧股骨近端和右肱骨。磁共振成像和计算机断层扫描显示多个椎体(T1、T5、T10和T12)有溶骨性病变。在T10的病例中,椎体完全破坏并累及后缘,导致椎体塌陷及随后脊髓狭窄的风险。因此,在使用苯氧苄胺和比索洛尔进行围手术期α和β肾上腺素能阻滞之后,实施了T8 - T12的后路内固定及T12的骨水泥强化术。在对手术和麻醉风险进行全面术前评估,并进行包括药物降压治疗在内的适当围手术期管理后,在置入相应椎弓根螺钉之前进行的T8 - T12后路内固定及T12骨水泥强化术,并未因转移性病变释放儿茶酚胺而导致高血压危象或血流动力学不稳定。据作者所知,这是第一份描述在转移性嗜铬细胞瘤患者中联合使用骨水泥强化和后路内固定以预防溶骨性椎体塌陷的报告。通过适当的术前措施,骨水泥强化后路内固定是一种稳定转移性恶性嗜铬细胞瘤椎体的安全方法。然而,应尽可能避免直接处理转移性病变,以将血流动力学并发症的风险降至最低。